CAT and early-onset autosomal dominant Alzheimer disease: An in vitro study also found that resveratrol treatment reduced the generation of ROS in immortalized lymphocytes from Alzheimer's disease patients or healthy controls, as well as upregulated the gene expression of antioxidant enzymes, like catalase (CAT), SOD, and antiaging factors, like Sirt1 and Sirt3 [79].